Understanding the impact of childhood cancer rates across sub-Saharan Africa

July 28, 2017

Collated Childhood cancer statistics in sub Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of paediatric cancer across this region.

On the African continent, only South Africa operates a childhood cancer registry on the national level. This new study brings together data from 16 of the smaller localised registers, collecting this scattered knowledge for the first time and presenting it in an accessible format.

Examining the data in context allows researchers to notice important trends, such as in Blantyre, Malawi's second-largest city. In Blantyre, the cumulative risk of a child developing Burkitt's Lymphoma -- a rare blood cancer -- is a startling two in every thousand. The study's authors call this incidence "remarkable." And the global research community is largely unaware of this. "Everything starts with awareness," says lead author Prof Cristina Stefan, Global Clinical Leader of Oncology for Roche Diagnostics International Ltd of Switzerland, and Director of the African Medical Research and Innovation Institute (AMRII). "It is highly necessary to publicise these data, which at the moment represent the best image of the malignant disease in children in the respective regions." Other factors, such as the prevalence of malaria and the Epstein-Barr virus, contribute to the unique epidemiology of childhood cancer in Africa.

Prof Stefan says: "Our colleagues can learn that the patterns and distribution of cancers in Africa are totally different from Europe and there is a need for further research into the roles of factors such as genetic predispositions, and the influence of infections and other comorbidities in the evolution of cancer.

"We have learned many universal lessons about data collection as we prepared this work. Our hope is that the publication of this monograph will open the forums for future discussions and that the work will be referenced for the better understanding of cancer in children in Africa and used to improve outcomes for children affected there."

In the meantime, the study has been published in an open access journal so that the data is freely available to help public health policy makers and health agencies better plan allocation of existing medical resources to help prevent deaths which would be avoidable in higher income countries.
Editor's Notes

The paper has been authored by: Cristina Stefan, Freddie Bray, Jacques Ferlay, D Maxwell Parkin and Biying Liu.

Citation information and links

Monograph: Stefan C, Bray F, Ferlay J, Parkin DM and Liu B (2017) Cancer of Childhood in sub-Saharan Africa ecancer



Editorial: Parkin DM and Stefan C (2017) Editorial: Childhood Cancer in sub-Saharan Africa ecancer



About ecancermedicalscience (ecancer.org)

ecancermedicalscience (ecancer) is the official open access journal of the Organisation of European Cancer Institutes (OECI) and the European Institute of Oncology (IEO), Milan.

The journal was established in 2007 by Professor Umberto Veronesi and Professor Gordon McVie with the mission to break down the financial barriers to accessing cancer research and education.

The journal is not for profit and only charges authors an article publication fee if they have specific funding for publishing. So far over 2000 authors have published for free. The journal is funded by the Swiss based ECMS foundation, educational grants, sponsorship and charitable donations.


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.